These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6249954)

  • 21. Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].
    Nahorski SR; Richardson A
    Br J Pharmacol; 1979 Jul; 66(3):469P-470P. PubMed ID: 230879
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of phospholipids on the binding of [3H]dihydroalprenolol to the beta-adrenergic receptor of rabbit heart membranes.
    Thang NX; Borsodi A; Wollemann M
    Biochem Pharmacol; 1980 Oct; 29(20):2791-7. PubMed ID: 6254538
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-adrenergic receptors in early human placenta characterization of [3H]-dihydroalprenolol binding.
    Falkay G; Kovacs L
    Life Sci; 1983 Apr; 32(14):1583-90. PubMed ID: 6300586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipolysis and beta-adrenergic receptor binding on adipocytes of spontaneously hypertensive rats.
    Nelson KM; Shepherd RE; Spitzer JA
    Biochem Med Metab Biol; 1987 Feb; 37(1):51-60. PubMed ID: 3032223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the negative cooperativity model for fat cell beta-adrenergic receptors.
    Malbon CC; Cabelli RJ
    Biochim Biophys Acta; 1978 Nov; 544(1):93-101. PubMed ID: 214152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a defect in the number of beta-adrenergic receptors and in the adenylate cyclase responsiveness to guanine nucleotides in fat cells after adrenalectomy.
    Thotakura NR; de Mazancourt P; Giudicelli Y
    Biochim Biophys Acta; 1982 Jul; 717(1):32-40. PubMed ID: 6285991
    [No Abstract]   [Full Text] [Related]  

  • 27. [3H-dihydroalprenolol binding to beta-adrenergic receptors in adipocyte membrane fractions of rats premedicated with estrogens].
    Cernohorský M; Hynie S
    Sb Lek; 1993; 94(1):63-70. PubMed ID: 7992000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal alpha- and beta-adrenergic receptors: comparison of [3H]dihydroalprenolol and [3H]WB 4101 binding with noradrenergic innervation in the rat.
    Crutcher KA; Davis JN
    Brain Res; 1980 Jan; 182(1):107-17. PubMed ID: 6243229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of (-)-[3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes.
    Meurs H; van den Bogaard W; Kauffman HF; Bruynzeel PL
    Eur J Pharmacol; 1982 Nov; 85(2):185-94. PubMed ID: 6295780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-)3h-dihydroalprenolol binding sites by cytoplasmic fractions.
    Watanabe Y; Lai RT; Higuchi H; Maeda H; Yoshida H
    Life Sci; 1981 Mar; 28(12):1399-405. PubMed ID: 6264246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Characteristics of lipolytic activities in the genetically obese Zucker fatty rats--experimental study on (-)-[3H]dihydroalprenolol binding in the intact fat cells].
    Matsumoto G
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1145-59. PubMed ID: 6141076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (--)[3H]-dihydroalprenolol binding and inhibition of histamine release.
    Masini E; Fantozzi R; Blandina P; Galli A; Bani-Sacchi T; Giotti A; Zilletti L; Mannaioni PF
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):171-6. PubMed ID: 6185855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
    Kinnier WJ; Chuang DM; Costa E
    Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a second desensitized state of beta-adrenergic receptor with low affinity for beta-antagonists and normal reactivity towards beta-agonists in adipocyte membranes previously exposed to beta-antagonists.
    Giudicelli Y; Lacasa D; Agli B
    Eur J Biochem; 1979 Sep; 99(3):457-62. PubMed ID: 227682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aliphatic alcohols and the inhibition by thiol chelating agents of the binding of [3H[ dihydroalprenolol to myocardial beta-adrenoceptors.
    Moustafa E; Wong M
    Gen Pharmacol; 1981; 12(6):439-44. PubMed ID: 6273256
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-[3H]Dihydroalprenolol binding in subcellular fractions of rat cortex following noradrenergic denervation.
    Giron LT; Davis JN
    Brain Res; 1981 Oct; 223(1):223-8. PubMed ID: 6269702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1984 Jul; 804(3):331-40. PubMed ID: 6146352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.